Europe Single-Cell Multi-Omics Market: Analysis and Forecast, 2023-2033

Table of Contents

Executive Summary

Scope of the Study

Research Methodology

1. Market

• 1.1. Global Market Outlook
  • 1.1.1. Product Definition
  • 1.1.2. Inclusion and Exclusion Criteria
• 1.2. Market Overview
  • 1.2.1. Key Findings
  • 1.2.2. Current Market Scenario
    • 1.2.2.1. For Researchers
    • 1.2.2.2. For Diagnostics
• 1.3. Industry Outlook
  • 1.3.1. Regulatory Framework
  • 1.3.2. Patent Analysis
    • 1.3.2.1. Awaited Technological Developments
    • 1.3.2.2. Patent Filing Trend (by Country)
    • 1.3.2.3. Patent Filing Trend (by Year)
  • 1.3.3. Key Trends
    • 1.3.3.1. Advancements in Imaging Techniques for Single-Cell Sequencing
    • 1.3.3.2. Use of Artificial Intelligence (AI) and Machine Learning (ML) in Single-Cell Multi-Omics
    • 1.3.3.3. Increased Development of Advanced Solution Based on Single-Cell Technology
  • 1.3.4. Opportunity Assessment
  • 1.3.5. Product Benchmarking
  • 1.3.6. Clinical Trials
• 1.4. COVID-19 Impact
  • 1.4.1. Pre-COVID-19
  • 1.4.2. During COVID-19
  • 1.4.3. Post COVID-19
• 1.5. Business Dynamics
  • 1.5.1. Impact Analysis
  • 1.5.2. Business Drivers
    • 1.5.2.1. Rising Number of Large-Scale Genomics Studies Leveraging Single-Cell RNA Sequencing (Sc-RNA)
    • 1.5.2.2. Use of Single-Cell Multi-Omics Approach for Screening and Diagnostics of Diseases Leading to Shift Toward Personalized Medicine
    • 1.5.2.3. Increasing Use of Single-Cell Multi-Omics for Drug Development
    • 1.5.2.4. Collaborations among Technology Providers and Life Sciences Companies for Accelerating the Research in Single-Cell Multi-Omics
  • 1.5.3. Business Restraints
    • 1.5.3.1. High Cost of Single-Cell Analysis and Sequencing
    • 1.5.3.2. Limited Availability of Large Online Data Storage and Analysis Platforms
  • 1.5.4. Business Opportunities
    • 1.5.4.1. Expansion into New Research Applications, Such as Single-Cell Metabolomics
    • 1.5.4.2. Increasing Adoption of Genomic-Based Medicine in Emerging Nations

2. Europe

• 2.1. Europe
  • 2.1.1. Key Findings and Opportunity Assessment
  • 2.1.2. Market Dynamics
    • 2.1.2.1. Impact Analysis
  • 2.1.3. Market Sizing and Forecast
    • 2.1.3.1. Europe Single-Cell Multi-Omics Market (by Country)
      • 2.1.3.1.1. Germany
      • 2.1.3.1.2. Italy
      • 2.1.3.1.3. U.K.
      • 2.1.3.1.4. Spain
      • 2.1.3.1.5. France
      • 2.1.3.1.6. Rest-of-Europe

3. Markets - Competitive Benchmarking & Company Profiles

• 3.1. Competitive Benchmarking
  • 3.1.1. Key Strategies and Developments
    • 3.1.1.1. Funding Activities
    • 3.1.1.2. New Offerings
    • 3.1.1.3. Mergers and Acquisitions
    • 3.1.1.4. Partnership, Collaboration, and Business Expansion
  • 3.1.2. Market Share Analysis
  • 3.1.3. Growth Share Analysis
    • 3.1.3.1. By Application
    • 3.1.3.2. By Omics Type
    • 3.1.3.3. By Product Type
  • 3.1.4. Visual Graphics of the Companies
  • 3.1.5. Multi-Omics Ecosystem Active Players
• 3.2. Company Profiles
  • 3.2.1. Menarini Group
    • 3.2.1.1. Company Overview
    • 3.2.1.2. Role of Menarini Group in the Single-Cell Multi-Omics Market
    • 3.2.1.3. Analyst Perspective
  • 3.2.2. QIAGEN NV
    • 3.2.2.1. Company Overview
    • 3.2.2.2. Role of QIAGEN NV in the Single-Cell Multi-Omics Market
    • 3.2.2.3. Financials
    • 3.2.2.4. Analyst Perspective
  • 3.2.3. Rarecells Diagnostics
    • 3.2.3.1. Company Overview
    • 3.2.3.2. Role of Rarecells Diagnostics in the Single-Cell Multi-Omics Market
    • 3.2.3.3. Analyst Perspective
  • 3.2.4. Scipio Bioscience
    • 3.2.4.1. Company Overview
    • 3.2.4.2. Role of Scipio Bioscience in the Single-Cell Multi-Omics Market
    • 3.2.4.3. Analyst Perspective
  • 3.2.5. Singleron Biotechnologies
    • 3.2.5.1. Company Overview
    • 3.2.5.2. Role of Singleron Biotechnologies in the Single-Cell Multi-Omics Market
    • 3.2.5.3. Recent Developments
    • 3.2.5.4. Analyst Perspective

List of Figures

• Figure 1: An Overview of Single-Cell Multi-Omics Sequencing Technologies
• Figure 2: Single-Cell Multi-Omics Market, Impact Analysis
• Figure 3: Single-Cell Multi-Omics Market (by Region), $Billion, 2022 and 2033
• Figure 4: Single-Cell Multi-Omics Market: Research Methodology
• Figure 5: Primary Research Methodology
• Figure 6: Bottom-Up Approach (Segment-Wise Analysis)
• Figure 7: Top-Down Approach (Segment-Wise Analysis)
• Figure 8: Single-Cell Multi-Omics Market, Patent Analysis (by Country), January 2018- March 2023
• Figure 9: Single-Cell Multi-Omics Market, Patent Analysis (by Year), January 2018-December2022
• Figure 10: Single-Cell Multi-Omics Market, Key Trends, Market Shift, 2022-2033
• Figure 11: Single-Cell Multi-Omics Market, Impact Analysis
• Figure 12: Global Data for Rare Diseases, 2020
• Figure 13: Companies Using Multi-Omics Approach in Research and Development of Drugs and Vaccines
• Figure 14: Advantages of Multi-Omics in Drug Discovery and Development
• Figure 15: Cost of Single Cell Sequencing (by Company)
• Figure 16: Some of the Advancements in Single-Cell Metabolomics
• Figure 17: Single-Cell Multi-Omics Market Share (by Region)
• Figure 18: Europe Single-Cell Multi-Omics Market, Incremental Opportunity (by Country), $Million, 2023-2033
• Figure 19: Europe Single-Cell Multi-Omics Market, $Billion, 2022-2033
• Figure 20: Europe Single-Cell Multi-Omics Market (by Country), % Share, 2022 and 2033
• Figure 21: Germany Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 22: Italy Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 23: U.K. Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 24: Spain Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 25: France Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 26: Rest-of-Europe Single-Cell Multi-Omics Market, $Million, 2022-2033
• Figure 27: Single-Cell Multi-Omics Market, Number of Key Developments and Strategies, January 2018-March 2023
• Figure 28: Funding Activities, January 2018-March 2023
• Figure 29: New Offerings, January 2018-March 2023
• Figure 30: Mergers and Acquisitions, January 2018-March 2023
• Figure 31: Partnership, Collaboration, and Business expansion, January 2018-March 2023
• Figure 32: Single-Cell Multi-Omics Market, Company Revenue Share Analysis, $Billion, 2022
• Figure 33: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Application), 2023-2033
• Figure 34: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Omics Type), 2023-2033
• Figure 35: Single-Cell Multi-Omics Market, Growth-Share Matrix (by Product Type), 2023-2033
• Figure 36: Single Cell Multi Omics Market, Visual Graphics of the Companies
• Figure 37: Menarini Silicon Biosystems: Product Portfolio
• Figure 38: QIAGEN NV: Product Portfolio
• Figure 39: QIAGEN NV: Overall Financials, $Million, 2020-2022
• Figure 40: QIAGEN NV: Net Revenue (by Segment), $Million, 2020-2022
• Figure 41: QIAGEN NV: Net Revenue (by Region), $Million, 2020-2022
• Figure 42: QIAGEN NV: R&D Expenditure, $Million, 2020-2020
• Figure 43: Rarecells Diagnostics: Product Portfolio
• Figure 44: Scipio Bioscience: Product Portfolio
• Figure 45: Singleron Biotechnologies: Product Portfolio

List of Tables

• Table 1: Single-Cell Multi-Omics Market, Key Developments Analysis, January 2018-March 2023
• Table 2: Key Questions Answered in the Report
• Table 3: Single-Cell Multi-Omics Market: Global Regulatory Organization
• Table 4: Single-Cell Multi-Omics Market, Product Benchmarking
• Table 5: Single-Cell Multi-Omics Market, Ongoing Clinical Trials
• Table 6: Single-Cell Multi-Omics Platforms Used in the Diagnosis of Disease
• Table 7: Recent Collaborations between Technology Providers and Life Sciences Companies
• Table 8: Europe Single-Cell Multi-Omics Market Dynamics, Impact Analysis
• Table 9: Multi-Omics Ecosystem Active Players